ORMP
ORAMED PHARMACEUTICALS INC.
NASDAQ · Healthcare · Biotechnology · US
$4.06
−0.25%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- $0.43
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.09
- EPS estimate
- $0.43
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +561.4%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | $0.43 | -$0.09 | Miss -120.93% | — |
| May 19, 2026 | — | -$0.16 | — | — |
| Nov 13, 2025 | -$0.04 | $1.13 | Beat 2925.00% | — |
| Aug 14, 2025 | -$0.04 | -$0.05 | Miss -25.00% | — |
| May 15, 2025 | -$0.03 | -$0.19 | Miss -533.33% | $2.0M |
| Mar 27, 2025 | -$0.03 | $0.01 | Beat 133.33% | — |
| Nov 7, 2024 | -$0.00 | -$0.48 | Miss -9695.92% | — |
| Aug 14, 2024 | $0.01 | $0.26 | Beat 2500.00% | — |
| May 9, 2024 | $0.02 | $0.04 | Beat 100.00% | — |
| Mar 6, 2024 | -$0.12 | -$0.08 | Beat 33.33% | — |
| Nov 9, 2023 | -$0.09 | -$0.08 | Beat 11.11% | — |
| Aug 10, 2023 | -$0.11 | -$0.03 | Beat 72.73% | $674.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026